Apotea Q2 FY26 EBIT rises 12.1% to SEK 104.4 million; net revenue increases 10.9% to SEK 2.03 billion

• Apotea Q2 net revenue rose 10.9% to SEK 2.03 billion; operating profit climbed to SEK 104.4 million, lifting EBIT margin 0.1 percentage point to 5.2%.
• Profit for the period increased to SEK 81.1 million; diluted EPS improved to SEK 0.78.
• H1 net revenue increased 10.7% to SEK 3.96 billion; operating profit rose to SEK 205.7 million, keeping EBIT margin flat at 5.2%.
• Operating cash flow fell to SEK 76.8 million in Q2; H1 operating cash flow declined to SEK 189.3 million.
• CEO Pär Svärdson cited scaling beauty and health sales in Norway via apotea.no; own brands now generate more than SEK 100 million in annual sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apotea AB (publ) published the original content used to generate this news brief on July 17, 2026, and is solely responsible for the information contained therein.